News & sentiment

SERNOVA BIOTHERAPEUT (SEOVF) — News & AI sentiment

SERNOVA BIOTHERAPEUT (SEOVF) news roundup. 7 stories in the past week, 8 over 30 days. Average 30-day sentiment is 52.6/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

7d stories

avg sentiment 53/100

30d stories

avg sentiment 52.6/100

Insider net (90d)

0 buys · 0 sells

Congress (90d)

0 buys · 0 sells

SEOVF news in the last 24 hours, 7 days, 30 days and 90 days

How much SEOVF coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	SEOVF stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	7	53/100	SEOVF headlines →
Last 30 days	8	52.6/100	SEOVF headlines →
Last 90 days	9	53.8/100	SEOVF headlines →

Latest stories on SEOVF

Sernova shareholder backs Seraxis takeover proposal

Seeking Alpha55 · neutralm&a

2d ago

Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc.

StockTitan50 · neutralgeneral

2d ago

Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

GlobeNewswire56 · neutralgeneral

3d ago

Sernova Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investor Conference

Business Insider56 · neutralproduct/pr

3d ago

Sernova price target lowered to C$1 from C$6 at H.C. Wainwright

The Fly28 · bearishanalyst

5d ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

Business Insider63 · neutralm&a

5d ago

Sernova and Seraxis Enter Definitive Merger Agreement to Create a Differentiated Type 1 Diabetes Islet Cell-Replacement Biotech Company, BetaNova Biotherapeutics

GlobeNewswire63 · neutralm&a

5d ago

Cell Encapsulation Global Market Report 2026-2035 | Features Strategic Profiles of Beta-Cell, Betalin Therapeutics, Beta-O2 Technologies, Diatranz Otsuka, Neurotech, Semma Therapeutics, Sernova, ViaCyte

GlobeNewswire50 · neutralgeneral

Aug 26

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | SEOVF Stock News

StockTitan63 · neutralproduct/pr

Jun 17

Open SEOVF in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →